亚洲 · 股市与财经 · Business Standard
Emcure Pharma up over 3% as board approves merger of two subsidiaries
Emcure Pharmaceuticals will merge its wholly owned subsidiaries, Zuventus Healthcare and Emcutix Biopharmaceuticals, with itself under the proposed scheme.
在 Business Standard 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.business-standard.com)
